abstract |
The present invention provides a novel compound of formula (I) or a pharmaceutically acceptable salt thereof, a pharmaceutical formulation containing said compound, the use of said active compound in therapy, a condition associated with glycogen synthase kinase-3 related disorders, such as the treatment of Alzheimer's disease. And for administering a therapeutically effective amount of said compound to a mammal, including a human, in need thereof. <Formula I> Wherein R 1 is hydrogen or fluoro; R 2 and R 3 are independently selected from hydrogen or methyl. |